Our findings of identified biological pathways demonstrated that the Metastasis and Recurrence groups with a higher expression of MUC16, the more significant discrepancy of the Metastasis group, compared to the Control group showed that cancer development played an important role in metastasis and that innate immunity played an important role in recurrence. This evidence concerns the gene MUC16 and cancer.